• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体在IgA肾病中的作用。

Role of complement in IgA nephropathy.

作者信息

Daha Mohamed R, van Kooten Cees

机构信息

Department of Nephrology, Leiden University Medical Center, Albinusdreef 2, 2333ZA, Leiden, The Netherlands.

出版信息

J Nephrol. 2016 Feb;29(1):1-4. doi: 10.1007/s40620-015-0245-6. Epub 2015 Nov 13.

DOI:10.1007/s40620-015-0245-6
PMID:26567162
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4733139/
Abstract

Immunoglobulin A nephropathy (IgAN) is characterized by the deposition of IgA in the mesangium of glomeruli. This mesangial IgA has been found to consist mainly of polymeric IgA1 which drives the activation of the mesangial cells and results in excessive production of several inflammatory mediators. The activation of mesangial cells is amplified by the ability of IgA to activate the complement system, originally thought to occur mainly via the alternative pathway of complement. However more recent studies indicate that lectin pathway involvement has a strong association with progression of renal disease. In this review we summarize the contribution of complement to the IgA- mediated inflammatory process.

摘要

免疫球蛋白A肾病(IgAN)的特征是IgA在肾小球系膜中沉积。已发现这种系膜IgA主要由聚合性IgA1组成,它驱动系膜细胞的激活,并导致多种炎症介质的过度产生。IgA激活补体系统的能力放大了系膜细胞的激活,最初认为补体激活主要通过补体替代途径发生。然而,最近的研究表明,凝集素途径的参与与肾脏疾病的进展密切相关。在这篇综述中,我们总结了补体在IgA介导的炎症过程中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/4733139/c1543b25dcd1/40620_2015_245_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/4733139/c1543b25dcd1/40620_2015_245_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/4733139/c1543b25dcd1/40620_2015_245_Fig1_HTML.jpg

相似文献

1
Role of complement in IgA nephropathy.补体在IgA肾病中的作用。
J Nephrol. 2016 Feb;29(1):1-4. doi: 10.1007/s40620-015-0245-6. Epub 2015 Nov 13.
2
Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis.IgA 肾小球肾炎中的系膜 IgA2 沉积及凝集素途径介导的补体激活
Am J Kidney Dis. 2001 Nov;38(5):1082-8. doi: 10.1053/ajkd.2001.28611.
3
Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.IgA肾病中补体凝集素途径的肾小球激活与更严重的肾脏疾病相关。
J Am Soc Nephrol. 2006 Jun;17(6):1724-34. doi: 10.1681/ASN.2005090923. Epub 2006 May 10.
4
Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.聚合免疫球蛋白A1与转铁蛋白受体的结合:IgA肾病中存在涉及受体表达增加和系膜细胞增殖的正反馈回路的证据。
J Am Soc Nephrol. 2005 Sep;16(9):2667-76. doi: 10.1681/ASN.2004111006. Epub 2005 Jun 29.
5
Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.IgA肾病患者的IgA1对人肾小球系膜细胞的结合能力及病理生理效应
Clin Exp Immunol. 2004 Apr;136(1):168-75. doi: 10.1111/j.1365-2249.2004.02408.x.
6
IgA production and tonsillar focal infection in IgA nephropathy.IgA肾病中的IgA产生与扁桃体局灶性感染
J Clin Exp Hematop. 2012;52(3):161-70. doi: 10.3960/jslrt.52.161.
7
Integrin α1/β1 and α2/β1 as a receptor for IgA1 in human glomerular mesangial cells in IgA nephropathy.在 IgA 肾病中,整合素 α1/β1 和 α2/β1 作为人肾小球系膜细胞中 IgA1 的受体。
Int Immunol. 2012 Apr;24(4):219-32. doi: 10.1093/intimm/dxr125. Epub 2012 Jan 31.
8
The role of complement in IgA nephropathy.补体在 IgA 肾病中的作用。
Mol Immunol. 2019 Oct;114:123-132. doi: 10.1016/j.molimm.2019.07.017. Epub 2019 Jul 24.
9
Immunopathogenesis of IgAN.IgA肾病的免疫发病机制。
Semin Immunopathol. 2007 Nov;29(4):427-43. doi: 10.1007/s00281-007-0089-9. Epub 2007 Sep 13.
10
[Progress in understanding the pathogenesis of IgA nephropathy: new perspectives for the near future?].[IgA肾病发病机制的认识进展:近期新视角?]
Nefrologia. 2010;30(5):501-7. doi: 10.3265/Nefrologia.pre2010.Jul.10526.

引用本文的文献

1
First-in-Class Clinically Investigated Oral Factor D Inhibitors for the Treatment of Complement-Mediated Diseases.用于治疗补体介导疾病的首个进入临床研究阶段的口服因子D抑制剂。
Pharm Res. 2025 Jun 25. doi: 10.1007/s11095-025-03882-8.
2
Modern Biomarkers in IgA Nephropathy and Their Potential in Paediatric Research.IgA肾病中的现代生物标志物及其在儿科研究中的潜力
J Clin Med. 2025 May 7;14(9):3263. doi: 10.3390/jcm14093263.
3
The Lectin Pathway of the Complement System-Activation, Regulation, Disease Connections and Interplay with Other (Proteolytic) Systems.

本文引用的文献

1
Factor H-related proteins determine complement-activating surfaces.补体激活表面由因子 H 相关蛋白决定。
Trends Immunol. 2015 Jun;36(6):374-84. doi: 10.1016/j.it.2015.04.008. Epub 2015 May 13.
2
Combined C4d and CD3 immunostaining predicts immunoglobulin (Ig)A nephropathy progression.C4d与CD3联合免疫染色可预测免疫球蛋白A(IgA)肾病的进展。
Clin Exp Immunol. 2015 Feb;179(2):354-61. doi: 10.1111/cei.12461.
3
Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA Nephropathy.
补体系统凝集素途径的激活、调控、疾病关联及与其他(蛋白水解)系统的相互作用。
Int J Mol Sci. 2024 Jan 26;25(3):1566. doi: 10.3390/ijms25031566.
4
Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy.当前对补体蛋白作为治疗免疫球蛋白 A 肾病的治疗靶点的理解。
Drugs. 2023 Nov;83(16):1475-1499. doi: 10.1007/s40265-023-01940-2. Epub 2023 Sep 25.
5
How to take advantage of easily available biomarkers in patients with IgA nephropathy: IgA and C3 in serum and kidney biopsies.如何利用 IgA 肾病患者易得的生物标志物:血清和肾活检中的 IgA 和 C3。
Pediatr Nephrol. 2023 May;38(5):1439-1448. doi: 10.1007/s00467-022-05644-9. Epub 2022 Aug 2.
6
The clinical and pathological characteristics of IgA nephropathy patients in Tibet.西藏地区 IgA 肾病患者的临床与病理特征。
BMC Nephrol. 2022 Jul 27;23(1):269. doi: 10.1186/s12882-022-02895-4.
7
Characterization of Purified Mulberry Leaf Glycoprotein and Its Immunoregulatory Effect on Cyclophosphamide-Treated Mice.纯化的桑叶糖蛋白的表征及其对环磷酰胺处理小鼠的免疫调节作用。
Foods. 2022 Jul 9;11(14):2034. doi: 10.3390/foods11142034.
8
A new pathological perspective on thrombotic microangiopathy.血栓性微血管病的一种新的病理学视角。
Kidney Res Clin Pract. 2022 Sep;41(5):524-532. doi: 10.23876/j.krcp.22.010. Epub 2022 Jun 21.
9
Discovering Immune-Mediated Mechanisms of Gastric Carcinogenesis Through Single-Cell RNA Sequencing.通过单细胞 RNA 测序发现胃癌发生的免疫介导机制。
Front Immunol. 2022 Jun 10;13:902017. doi: 10.3389/fimmu.2022.902017. eCollection 2022.
10
Role of C4d in the Diagnosis and Prognosis of Native Renal Diseases.C4d在原发性肾脏疾病诊断及预后中的作用
Indian J Nephrol. 2022 Mar-Apr;32(2):97-103. doi: 10.4103/ijn.IJN_251_20. Epub 2022 Mar 11.
补体因子H及补体因子H相关蛋白基因CFHR3和CFHR1的变异影响IgA肾病中的补体激活。
J Am Soc Nephrol. 2015 May;26(5):1195-204. doi: 10.1681/ASN.2014010096. Epub 2014 Sep 9.
4
Eculizumab treatment for rescue of renal function in IgA nephropathy.依库珠单抗治疗IgA肾病以挽救肾功能
Pediatr Nephrol. 2014 Nov;29(11):2225-8. doi: 10.1007/s00467-014-2863-y. Epub 2014 Jun 13.
5
Association of C4d deposition with clinical outcomes in IgA nephropathy.IgA肾病中C4d沉积与临床结局的关联
Clin J Am Soc Nephrol. 2014 May;9(5):897-904. doi: 10.2215/CJN.09710913. Epub 2014 Feb 27.
6
New insights into the pathogenesis of IgA nephropathy.IgA肾病发病机制的新见解。
Semin Immunopathol. 2014 Jul;36(4):431-42. doi: 10.1007/s00281-013-0411-7. Epub 2014 Jan 18.
7
IgA nephropathy.IgA肾病
N Engl J Med. 2013 Jun 20;368(25):2402-14. doi: 10.1056/NEJMra1206793.
8
Glomerular and tubular C4d depositions in IgA nephropathy: relations with histopathology and with albuminuria.IgA肾病中肾小球和肾小管C4d沉积:与组织病理学及蛋白尿的关系
Int J Clin Exp Pathol. 2013 Apr 15;6(5):904-10. Print 2013.
9
IgA nephropathy: molecular mechanisms of the disease.IgA 肾病:疾病的分子机制。
Annu Rev Pathol. 2013 Jan 24;8:217-40. doi: 10.1146/annurev-pathol-011110-130216. Epub 2012 Oct 18.
10
The complement system in ischemia-reperfusion injuries.补体系统在缺血再灌注损伤中的作用。
Immunobiology. 2012 Nov;217(11):1026-33. doi: 10.1016/j.imbio.2012.07.024. Epub 2012 Aug 7.